March

March 2, 2015

MiRNA-based therapy for Cardiac Ischemic injury: MiRNA-329 decreases infarct size and remodelling and augments cardiac function via down regulation of its target gene, 2/March/2016, 9.03 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for Cardiac Ischemic injury: MiRNA-329 decreases infarct size and remodelling and augments cardiac function via […]
March 2, 2015

Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of tumor suppressor RECK via down regulation of its target gene, 2/March/2015, 8.51 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of tumor suppressor RECK via […]
March 1, 2015

MiRNA-based therapy for weight loss: MiRNA-202 decreases the expression of Low density lipoprotein receptor-related protein 6 and promotes weight loss via down regulation of its target gene, 1/March/2015, 23.05

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, MiRNA-based therapy for weight loss: MiRNA-202 decreases the expression of Low density lipoprotein receptor-related protein 6 […]
March 1, 2015

Natural product-based therapy for Cancer: Nonivamide increases the expression of tumor suppressor INK4a/p16 via down regulation of its target gene, 1/March/2015, 22.25

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Significance:  This study suggests, for the first time, Nonivamide, by suppressing the expression of its target gene, it may increase the […]